Public consultation on applications to be considered by the MSAC (July 2023)

Closes 10 Jun 2023

Opened 22 Feb 2023


Consultation is now open for applications that are anticipated to be considered by the Medical Services Advisory Committee (MSAC) on 27-28 July 2023  

MSAC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies being addressed by the application.   

It is anticipated that the below-mentioned applications will proceed to MSAC in July 2023. Consultation input must be received by no later than          Friday, 9 June 2023 for it to be considered by MSAC. A consultation survey form is available on the relevant application webpage.

Further information on MSAC’s consultation process is also available on the MSAC website.

Applications scheduled to be considered:


1686.1 –177Lutetium PSMA i&t for metastatic castrate resistant prostate cancer

1689.1 - Quantification of NT-proBNP in patients with systemic sclerosis, and in patients with diagnosed pulmonary arterial hypertension

New submissions:


1657 – Rhenium-188 brachytherapy for non-melanoma skin cancer

1710 – Newborn bloodspot screening for X-linked adrenoleukodystrophy

1732 – Imlifidase as a desensitisation treatment to enable kidney transplant in highly sensitised adult transplant candidates

1737 – Newborn bloodspot screening for Sickle Cell Disease and Beta Thalassaemia

1747 – Permanent Medicare Benefits Schedule (MBS) items for COVID-19 nucleic acid testing

1748 – Review of Tisagenlecleucel for treatment of confirmed relapsed/refractory CD19-positive acute lymphoblastic leukaemia in children and young adults up to 25 years old


How to provide input to MSAC

To provide input on any of the applications listed, please click on the relevant application link above this box. This will take you to the relevant MSAC webpage where you will be able to download and complete a consultation survey.

Alternatively, you can provide a separate file with your input to

Guidance on what sort of information to include in your consultation input can be found on the MSAC website. 

Consumers and consumer groups and organisations are welcome to contact the Consumer Evidence and Engagement Unit for questions on current consultations


  • Anyone from any background


  • All